FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
- FDA: 31 events in the last 90 days
- Previous: earlier the same day · Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk
What happened
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
Summary assembled by rule from the sources below